Corrigendum to “Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up” [Clin Microbiol Infect] 29 (7) (2023) 918–923 (Clinical Microbiology and Infection (2023) 29(7) (918–923), (S1198743X23001210), (10.1016/j.cmi.2023.03.007))

Noam Barda, Yaniv Lustig, Victoria Indenbaum, Daniel Zibly, Gili Joseph, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Limor Kliker, Bian Abu-Kadar, Eytan Ben-Ami, Michal Canetti, Ravit Koren, Shiri Katz-Likvornik, Osnat Halpern, Ella Mendelson, Ram Doolman, Dror Harats, Yitshak Kreiss, Michal MandelboimGili Regev-Yochay

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Corrigendum to “Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up” [Clin Microbiol Infect] 29 (7) (2023) 918–923 (Clinical Microbiology and Infection (2023) 29(7) (918–923), (S1198743X23001210), (10.1016/j.cmi.2023.03.007))'. Together they form a unique fingerprint.

Medicine & Life Sciences